Literature DB >> 1409369

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

C C Peck1, W H Barr, L Z Benet, J Collins, R E Desjardins, D E Furst, J G Harter, G Levy, T Ludden, J H Rodman.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1409369     DOI： 10.1023/a:1015824110164

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  7 in total

Review 1.  Pharmacokinetic-pharmacodynamic profile of angiotensin II receptor antagonists.

Authors:  C Csajka; T Buclin; H R Brunner; J Biollaz
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

2.  Are we doing too many animal biodisposition investigations before phase I studies in man? A re-evaluation of the timing and extent of ADME studies.

Authors:  D B Campbell
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Jul-Sep       Impact factor: 2.441

3.  Interpretation and utilization of effect and concentration data collected in an in vivo pharmacokinetic and in vitro pharmacodynamic study.

Authors:  S K Gupta; S S Hwang; L Z Benet; M Gumbleton
Journal:  Pharm Res       Date:  1993-06       Impact factor: 4.200

4.  An HPLC assay for the lipophilic camptothecin analog AR-67 carboxylate and lactone in human whole blood.

Authors:  Eleftheria Tsakalozou; Jamie Horn; Mark Leggas
Journal:  Biomed Chromatogr       Date:  2010-10       Impact factor: 1.902

Review 5.  Role of population pharmacokinetics in drug development. A pharmaceutical industry perspective.

Authors:  E Samara; R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

Review 6.  Moving from basic toward systems pharmacodynamic models.

Authors:  William J Jusko
Journal:  J Pharm Sci       Date:  2013-05-16       Impact factor: 3.534

7.  Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation.

Authors:  S F Marshall; R Burghaus; V Cosson; S Y A Cheung; M Chenel; O DellaPasqua; N Frey; B Hamrén; L Harnisch; F Ivanow; T Kerbusch; J Lippert; P A Milligan; S Rohou; A Staab; J L Steimer; C Tornøe; S A G Visser
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.